Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyslipidemia in Patients With Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00699023
What this trial is testing

Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

Who this might be right for
Postprandial LipemiaType 2 Diabetes
Federico II University 13
Large-scale testing (Phase 3)Looking for participantsNCT06772168
What this trial is testing

Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

Who this might be right for
DyslipidemiaType 2 Diabetes
CMG Pharmaceutical Co. Ltd 240
Post-approval studies (Phase 4)Study completedNCT02185963
What this trial is testing

Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes

Who this might be right for
Diabetes
Seoul National University Bundang Hospital 50
Post-approval studies (Phase 4)Study completedNCT00645424
What this trial is testing

Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

Who this might be right for
Hyperlipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 155
Testing effectiveness (Phase 2)Study completedNCT00236626
What this trial is testing

The Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Not applicableUnknownNCT03204799
What this trial is testing

Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes

Who this might be right for
Type 2 Diabetes MellitusDyslipidemias
Yonsei University 150
Post-approval studies (Phase 4)Ended earlyNCT00640549
What this trial is testing

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

Who this might be right for
HyperlipidemiaDiabetes Mellitus, Type 2Non-Insulin Dependent Diabetes Mellitus
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 41
Post-approval studies (Phase 4)Study completedNCT03217409
What this trial is testing

Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

Who this might be right for
Diabetes Mellitus and Hypercholesterolemia
Yuhan Corporation 85
Not applicableStudy completedNCT00526552
What this trial is testing

Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)

Who this might be right for
DyslipidemiaDiabetes
AstraZeneca 5,000
Not applicableUnknownNCT00797186
What this trial is testing

Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus

Who this might be right for
Type 2 DiabetesMicrovascular Dysfunction
University of Virginia 150
Post-approval studies (Phase 4)Study completedNCT02642159
What this trial is testing

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Who this might be right for
Dyslipidemia
Sanofi 413
Post-approval studies (Phase 4)Study completedNCT01384058
What this trial is testing

Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2Hypercholesterolemia
University Hospital Freiburg 41
Post-approval studies (Phase 4)Study completedNCT01422421
What this trial is testing

Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

Who this might be right for
Type 2 DiabetesCoronary Artery DiseaseHypertension+1 more
Takeshi Morimoto 798
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Large-scale testing (Phase 3)Ended earlyNCT00762112
What this trial is testing

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 316
Large-scale testing (Phase 3)Ended earlyNCT00762957
What this trial is testing

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 15
Post-approval studies (Phase 4)Study completedNCT00770445
What this trial is testing

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 121
Not applicableStudy completedNCT00432029
What this trial is testing

Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers.

Who this might be right for
Diabetes Mellitus, Type 1HypertensionHypercholesterolemia+1 more
Medical University of Vienna 80
Large-scale testing (Phase 3)Ended earlyNCT00762684
What this trial is testing

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 8
Next Page